Navigation Links
Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
Date:3/6/2009

CORONA, Calif., March 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that it has reached a settlement with Elan Corporation, Plc on outstanding patent litigation related to Watson's generic version of Naprelan(R) (naproxen sodium) tablets.

Under the terms of the agreement, Watson will pay Elan $18 million in full settlement of all disputes related to Watson's development, manufacturing, marketing and sale of its naproxen sodium product. Watson also has agreed not to market or sell its naproxen sodium product until the expiration or final finding of invalidity or unenforceability of U.S. Patent No. 5,637,320. Other details concerning the settlement have not been disclosed.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes generic and specialty brand pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceutical's Web site at http://www.watson.com.

Watson's Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectation
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
2. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
3. Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
4. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
5. Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
6. U.S. Workers Taking Steps to Lower Medical Costs, Watson Wyatt Survey Finds
7. China Shenghuo Announces Additional Roll-Out of 12 Ways Cosmetics Products to Watsons Stores
8. Driving Consumer Engagement Is Focus of Address by Healthfitness Chief Medical Officer at Watson Wyatt Health Care Solutions Event
9. Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
10. Watson Enters Into Agreement to Acquire Products Related to Tevas Proposed Acquisition of Barr
11. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Alan Revell of Milford ... before he quit. What he witnessed was the inspiration for the ... "I just knew that there had to be a better way ... Rose Home Care. "What I saw in just one day was ... but I knew right then that we needed to find a ...
(Date:2/9/2010)... nutrition to cut obesity, ensure qualified recruits ,, ... General Johnnie E. Wilson , U.S. Army (Ret.), ... Force (Ret.), said Tuesday that preventing child obesity is ... has become the Number 1 reason why potential recruits ... generals, comments came in support of First Lady ...
(Date:2/9/2010)... MOUNTAIN VIEW, Calif. , Feb. 9 /PRNewswire/ ... of San Jose, California , has been re-elected ... Nurses, Association (ANNA) for 2010-11. ,, Doss, ... her position during ANNA,s 41st National Symposium ... 2010 . ,, As Western CCE, Doss will coordinate ...
(Date:2/9/2010)... training school, Pima Medical Institute, a leading private medical career ... program, the Bachelor of Science in Radiologic Sciences. This online ... school, and is also the first bachelor,s degree approved by ... Education Schools (ABHES). , ... Tucson, ...
(Date:2/9/2010)... features videos, chat, extensive smile gallery and other resources and ... ... York, NY (PRWEB) February 9, 2010 -- Leading specialists in ... City office announces the launch of its new Web site, ... and helpful information regarding the office’s services and cosmetic dental ...
Breaking Medicine News(10 mins):Health News:Caring Rose Home Care Launched To Help Seniors Live Independently 2Health News:Retired Military Brass Support First Lady's Call to Reduce Child Obesity, Improve Nutrition 2Health News:Satellite Healthcare's Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses' Association 2Health News:Satellite Healthcare's Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses' Association 3Health News:Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program 2Health News:Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program 3Health News:Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program 4Health News:Top New York Dentists at Smile in the City Launch New Web Site 2
... cracked the mystery of the deaths of thousands of ... ,Eye and throat disease had killed the young farmed ... farms in recent past weeks. ,Veterinary pathologist ... cold dry season and exposure of hatchlings to older ...
... Zealand are not getting enough sun, and as a ... making a comeback, experts have revealed in the latest ... nutritional rickets are again emerging as major paediatric health ... Munns, paediatric endocrinologist at the Children’s Hospital at Westmead, ...
... an outbreak of the deadly bird flu following reports of ... first of these cases was reported in the village of ... miles south of Cairo. ,Following this report all ... to check that none of the people who had been ...
... advice to women of childbearing age, who would indeed be ... of delivering a child with birth defects. // , ... with intake of vitamins and minerals, the risk of many ... be offset include neural-tube defects such as spina bifida, brain-damaging ...
... medical students are unprepared for skilled prescribing, warn doctors ... UK is abundant, write Jeffrey Aronson and colleagues.// Effective ... especially when new doctors start work in hospitals. ... say the authors. Some relate to system failures, while ...
... diabetes in pregnancy has increased four times among Australian women ... may cause problems for babies. In NSW the rate has ... Australia NSW president Neville Howard said it was a dangerous ... change so dramatic that record numbers of pregnant mothers in ...
Other Medicine News:Health News:More Sunshine for At-Risk Kids 2Health News:Many Medical Students Unprepared for Skilled Prescribing 2
(Date:2/9/2010)... 9 Palatin Technologies, Inc. (NYSE ... of first cohort dosing in a placebo-controlled, multiple ... sexual dysfunction.  The primary endpoint in this double-blind ... of subcutaneous bremelanotide in men between 45 and ... consistency of plasma exposure of bremelanotide given as ...
(Date:2/8/2010)... Cost reductions offset a recession-driven sales decline ... narrowly back into profitability in the second quarter of ... December 31, 2009 declined almost 9 percent, ... quarter last year to $11.4 million in ... reduced even more sharply, from approximately $9.8 million ...
(Date:2/8/2010)... Initiative Drives Awareness for Improving the Safety of ... PARK, N.J. , Feb. 8 /PRNewswire-USNewswire/ ... of a new initiative to promote safer medication ... based on the American Society for Parenteral and ... The "Be A.W.A.R.E." campaign is designed to increase ...
Breaking Medicine Technology:Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 2Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 3Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 2Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 3Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 4Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety 5Genetic Variant Slows AIDS Progression 61923 1Genetic Variant Slows AIDS Progression 61923 2Isis Pharmaceuticals 28Nasdaq 3A ISIS 29 Letter to Shareholders 61919 1Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 1Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 2
... Primary Tumors From Metastases in the ... With Accuracy Near 90%, Identifying Whether a Brain Malignancy is a Primary Tumor or ... Primary From Metastatic Tumors is Critical for ... Optimal Treatment, REHOVOT, Israel and JERSEY CITY, New ...
... , - PREVENAR Vaccine to Help ... Death in Young Children, Wyeth applauds ... of,Bahrain, Republic of Ireland, Slovak Republic and ... infants and young children against,pneumococcal disease by ...
Other Medicine Technology:Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 2Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 3Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 4Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 2Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 3
... The proven design of the Custom ... osteoarthritis by applying three-point load across ... form the degenerative area. The Diagonal ... ability to adjust the load to ...
... of the TROM provides the same easy ... as the full foam TROM, but is ... of use and versatility of the Cool ... following major ligament surgery, meniscal repairs, patella ...
... Fource Point Technology was developed to further ... of Leverage brace design. The patented Fource Point ... and offer an increasing resistance in the last ... extension shock and increase posterior tibial loads. The ...
Provides support and immobilization of the knee...
Medicine Products: